6,9-bridged erythromycin derivatives
    7.
    发明授权
    6,9-bridged erythromycin derivatives 失效
    6,9桥红霉素衍生物

    公开(公告)号:US5780605A

    公开(公告)日:1998-07-14

    申请号:US925582

    申请日:1997-09-08

    CPC分类号: C07H17/08

    摘要: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.

    摘要翻译: 具有抗细菌活性的新型多环红霉素化合物及其药学上可接受的盐和酯具有式(I),(II),图像(III)的组合物,包含治疗有效量的本发明化合物 与药学上可接受的载体的组合,以及通过向哺乳动物施用含有治疗有效量的本发明化合物的药物组合物来治疗细菌感染的方法。